Oxygenta Pharmaceutical (BOM:524636) Net Income (Continuing Operations) : ₹-34.8 Mil (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Oxygenta Pharmaceutical Net Income (Continuing Operations)?

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Oxygenta Pharmaceutical's Net Income (Continuing Operations) for the three months ended in Mar. 2024 was ₹75.9 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-34.8 Mil.

Oxygenta Pharmaceutical Net Income (Continuing Operations) Historical Data

The historical data trend for Oxygenta Pharmaceutical's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxygenta Pharmaceutical Net Income (Continuing Operations) Chart

Oxygenta Pharmaceutical Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Net Income (Continuing Operations)

Get a 7-Day Free Trial

-57.88

29.30

-6.11

-115.71

-34.79

Oxygenta Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income (Continuing Operations)	Get a 7-Day Free Trial															-42.91	-45.59	-31.60	-33.56	75.95

Oxygenta Pharmaceutical Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-34.8 Mil.

Oxygenta Pharmaceutical (BOM:524636) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Oxygenta Pharmaceutical Net Income (Continuing Operations) Related Terms

Thank you for viewing the detailed overview of Oxygenta Pharmaceutical's Net Income (Continuing Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

Oxygenta Pharmaceutical (BOM:524636) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Oxygenta Pharmaceutical Ltd (BOM:524636) » Definitions » Net Income (Continuing Operations)

Traded in Other Exchanges

N/A

Address

Plot no: 43, The Park View 1st Floor, Beside Sky View Suites (Saketa Nilayam), Behind Preston Prime Mall, Lumbini Avenue, Gachibowli, Hyderabad, TG, IND, 500032

Website

http://oxygentapharma.com

Oxygenta Pharmaceutical Ltd is a pharmaceutical company. It is engaged in the business activity of manufacturing bulk drugs and API. It specializes in manufacturing anti ulcerative and anti-bacterial drugs. The Company has one reportable segment which is Pharmaceutical. The group carries its business operations within India.

Oxygenta Pharmaceutical (BOM:524636) Headlines

No Headlines